The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Safety and efficacy of docetaxel + b-701, a selective inhibitor of FGFR3, in subjects with advanced or metastatic urothelial carcinoma.
 
Joaquim Bellmunt
Consulting or Advisory Role - Astellas Pharma; Genentech; Merck; Novartis; Pfizer; Pierre Fabre
Research Funding - Millennium (Inst); Sanofi (Inst)
Travel, Accommodations, Expenses - MSD Oncology; Pfizer
 
Sumanta K. Pal
Honoraria - Astellas Pharma; Medivation; Novartis
Consulting or Advisory Role - Astellas Pharma; Aveo; Bristol-Myers Squibb; Exelixis; Genentech; Myriad Pharmaceuticals; Novartis; Pfizer
Research Funding - Medivation
 
Joel Picus
Consulting or Advisory Role - Novo Nordisk
Research Funding - Agensys (Inst); Altor BioScience (Inst); Astex Pharmaceuticals (Inst); BioClin Therapeutics (Inst); Innocrin Pharma (Inst); Mirati Therapeutics (Inst); Novartis (Inst); Oncogenex (Inst); Rexahn Pharmaceuticals (Inst)
 
Manish Kohli
No Relationships to Disclose
 
Yull Edwin Arriaga
Consulting or Advisory Role - AstraZeneca; Boston Biomedical; Genentech
Speakers' Bureau - AstraZeneca
 
Matthew I. Milowsky
Research Funding - Acerta Pharma (Inst); BioClin Therapeutics (Inst); Bristol-Myers Squibb (Inst); Cerulean Pharma (Inst); Incyte (Inst); Innocrin Pharma (Inst); Inovio Pharmaceuticals (Inst); MedImmune (Inst); Merck (Inst); Mirati Therapeutics (Inst); Pfizer (Inst); Roche/Genentech (Inst); Seagen (Inst); X4 Pharma (Inst)
Travel, Accommodations, Expenses - Roche/Genentech
 
Jocelyn Holash
Employment - BioClin Therapeutics; Roche Molecular Diagnostics (I)
Leadership - BioClin Therapeutics
Stock and Other Ownership Interests - BioClin Therapeutics; Novartis; Regeneron; Roche (I)
Patents, Royalties, Other Intellectual Property - BioClin Therapeutics
 
David Albert Ramies
Employment - Exelixis
Stock and Other Ownership Interests - Ramies Consulting, Inc; Ramies Consulting, Inc (I)
Consulting or Advisory Role - BioClin Therapeutics
 
Jesse S. McGreivy
Employment - Acerta Pharma; BioClin Therapeutics
Leadership - Acerta Pharma; BioClin Therapeutics
Stock and Other Ownership Interests - Acerta Pharma; BioClin Therapeutics
Consulting or Advisory Role - BioClin Therapeutics; Presage Biosciences; Sunesis Pharmaceuticals